Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
PD-L1 Expression after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancers Is Associated with Aggressive Residual Disease, Suggesting a Potential for Immunotherapy.
Cancers (Basel). 2021 Feb 11;13(4):746. doi: 10.3390/cancers13040746.
Cancers (Basel). 2021.
PMID: 33670162
Free PMC article.
Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer.
Hamy AS, Derosa L, Valdelièvre C, Yonekura S, Opolon P, Priour M, Guerin J, Pierga JY, Asselain B, De Croze D, Pinheiro A, Lae M, Talagrand LS, Laas E, Darrigues L, Grandal B, Marangoni E, Montaudon E, Kroemer G, Zitvogel L, Reyal F.
Hamy AS, et al. Among authors: talagrand ls.
Oncoimmunology. 2019 Nov 14;9(1):1677427. doi: 10.1080/2162402X.2019.1677427. eCollection 2020.
Oncoimmunology. 2019.
PMID: 32002287
Free PMC article.
Item in Clipboard
Cite
Cite